(
SEVAMED 2003)
(Diagnosis,
Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis,
Vaccines & Drugs)
January 2003
5986.
Chang HH, Shyu HF, Wang YM, Sun DS, Shyu RH, Tang SS, Huang YS.
Facilitation of cell adhesion by immobilized dengue viral nonstructural protein
1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue
viral NS1 antigen. J Infect Dis 2002
Sep 15;186(6):743-51
5987.
Drosten C, Gottig S, Schilling S, Asper M, Panning M, Schmitz H, Gunther
S. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa
virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue
virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin
Microbiol 2002 Jul;40(7):2323-30
5988.
Endy TP, Nisalak A, Chunsuttiwat S, Libraty DH, Green S, Rothman AL,
Vaughn DW, Ennis FA. Spatial and temporal circulation of dengue virus serotypes:
a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J
Epidemiol 2002 Jul 1;156(1):52-9
5989.
Garcia-Rivera EJ, Rigau-Perez JG. Encephalitis and dengue. Lancet
2002 Jul 20;360(9328):261
5990.
Jacobs M, Levin M. An improved endothelial barrier model to investigate
dengue haemorrhagic fever. J Virol Methods
2002 Jul;104(2):173-85
5991.
King CA, Anderson R, Marshall JS. Dengue virus selectively induces human
mast cell chemokine production. J Virol 2002
Aug;76(16):8408-19
5992.
Rahman M, Rahman K, Siddque AK, Shoma S, Kamal AH, Ali KS, Nisaluk A,
Breiman RF. First outbreak of dengue hemorrhagic fever, Bangladesh. Emerg Infect
Dis 2002 Jul;8(7):738-40
5993.
Rele MC, Rasal A, Deshpande SD, Koppikar GV, Lahiri KR. Indian J med
Microbiol. 2001; 19(4): 206-7.
5994.
Van Gorp EC, Setiati TE, Mairuhu AT, Suharti C, Cate Ht H, Dolmans WM,
Van Der Meer JW, Hack CE, Brandjes DP. Impaired fibrinolysis in the pathogenesis
of dengue hemorrhagic fever. J Med Virol 2002
Aug;67(4):549-54
5995.
Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, Chau NV,
Chambers M, Stepniewska K, Farrar JJ, Levin M. Coagulation abnormalities in
dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with
Dengue shock syndrome. Clin Infect Dis 2002
Aug 1;35(3):277-85
Pathogenesis:
5996.
Blaney JE Jr, Johnson DH, Manipon GG, Firestone CY, Hanson CT, Murphy BR,
Whitehead SS. Genetic basis of attenuation of dengue virus type 4 small plaque
mutants with restricted replication in suckling mice and in SCID mice
transplanted with human liver cells. Virology. 2002 Aug 15;300(1):125-39.
5997.
Caplen NJ, Zheng Z, Falgout B, Morgan RA. Inhibition of viral gene
expression and replication in mosquito cells by dsRNA-triggered RNA
interference. Mol Ther. 2002 Aug;6(2):243-51.
5998.
Hales S, de Wet N, Maindonald J, Woodward A. Potential effect of
population and climate changes on global distribution of dengue fever: an
empirical model. Lancet. 2002 Sep 14;360(9336):830-4.
5999.
Kochel TJ, Watts DM, Halstead SB, Hayes CG, Espinoza A, Felices V, Caceda
R, Bautista CT, Montoya Y, Douglas S, Russell KL. Effect of dengue-1 antibodies
on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet. 2002
Jul 27;360(9329):310-2.
6000.
Lin CF, Lei HY, Shiau AL, Liu HS, Yeh TM, Chen SH, Liu CC, Chiu SC, Lin
YS. Endothelial cell apoptosis induced by antibodies against dengue virus
nonstructural protein 1 via production of nitric oxide. J Immunol. 2002 Jul
15;169(2):657-64.
6001.
Perelygin AA, Scherbik SV, Zhulin IB, Stockman BM, Li Y, Brinton MA.
Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci
U S A. 2002 Jul 9;99(14):9322-7.
Therapy:
6002. Johnson O. Venezuela launches new campaign against dengue fever. BMJ 2002 Sep 7;325(7363):512
6003.Teixeira Mda G, Barreto ML, Costa Mda C, Ferreira LD, Vasconcelos PF, Cairncross S. Dynamics of dengue virus circulation: a silent epidemic in a complex urban area. Trop Med Int Health 2002 Sep;7(9):757-62
April 2003
6634.
Arora MM; Mishra KB; Nair V; Bhardwaj JR; Bhalwar R; Somani BL.
Diagnosing disseminated intravascular coagulation in acute infection :
can we do without FDP & D-DIMER. Medical Journal Armed Forces India. 2002
Jan; 58(1): 13-7.
6635.
Dutta P , Khan S A , Khan A M , Sharma C K , Doloi P K , Mahant J .
Soloid waste pollution and breeding Potential of dengue vector in urban and
industrial environment of Assam
J envir biol ,Lucknow 1999,20(4),343-5.
6636.
Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S,
Vaughn DW, Nisalak A, Ennis FA, Rothman AL. High circulating levels of the
dengue virus nonstructural protein NS1 early in dengue illness correlate with
the development of dengue hemorrhagic fever.
J Infect Dis
2002 Oct 15;186(8):1165-8
Pathogenesis:
6637.
Lin YL, Lei HY, Lin YS, Yeh TM, Chen SH, Liu HS. Heparin inhibits
dengue-2 virus infection of five human liver cell lines. Antiviral Res
2002 Oct;56(1):93-6
6638.
Lin
YW, Wang KJ, Lei HY, Lin YS, Yeh TM, Liu HS, Liu CC, Chen SH. Virus replication
and cytokine production in dengue virus-infected human B lymphocytes. J Virol
2002 Dec;76(23):12242-9
Vaccines:
6639.
Halstead SB, Deen J. The future of dengue vaccines. Lancet
2002 Oct 19;360(9341):1243-5
Therapy:
6640.
Van Benthem BH, Khantikul N, Panart K, Kessels PJ, Somboon P, Oskam L.
Knowledge and use of prevention measures related to denguen northern Thailand.
Trop Med Int Health
2002 Nov;7(11):993-1000
July 2003
7134.
Espina LM, Valero NJ, Hernandez JM, Mosquera JA. Increased apoptosis and
expression of tumor necrosis factor-alpha caused by infection of cultured human
monocytes with dengue virus. Am J Trop Med Hyg 2003
Jan;68(1):48-53
7135.
Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, Yeh TM, Chen SH, Lin YS.
Antibodies from dengue patient sera cross-react with endothelial cells and
induce damage. J Med Virol
2003 Jan;69(1):82-90
7136.
Mairuhu AT, Mac Gillavry MR, Setiati TE, Soemantri A, ten Cate H,
Brandjes DP, van Gorp EC. Is clinical outcome of dengue-virus infections
influenced by coagulation and fibrinolysis? A critical review of the evidence.
Lancet Infect Dis 2003
Jan;3(1):33-41
7137.
Yocupicio-Monroy RM, Medina F, Reyes-del Valle J, del Angel RM. Cellular
proteins from human monocytes bind to dengue 4 virus minus-strand 3'
untranslated region RNA. J Virol
2003 Mar;77(5):3067-76
Pathogenesis:
7138.
Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, Yeh TM, Chen SH, Lin YS.
Antibodies from dengue patient sera cross-react with endothelial cells
and induce damage. J Med Virol. 2003 Jan;69(1):82-90.
7139.
Oliveira SA, Siqueira MM, Camacho LA, Castro-Silva R, Bruno BF, Cohen BJ.
Use of RT-PCR on oral fluid samples to assist the identification of
measles cases during an outbreak. Epidemiol Infect. 2003 Feb;130(1):101-6.
7140.
Suksanpaisan L, Smith DR.
Analysis of saturation binding and saturation infection for dengue
serotypes 1 and 2 in liver cells. Intervirology. 2003;46(1):50-5.
7141. Yocupicio-Monroy RM, Medina F, Reyes-del Valle J, del Angel RM. Cellular proteins from human monocytes bind to dengue 4 virus minus-strand 3' untranslated region RNA. J Virol. 2003 Mar;77(5):3067-76.
October 2003
7859.
Imbert-Laurenceau E, Crepinior J, Crance JM, Jouan A, Migonney V.
Polystyrene derivatives substituted with arginine interact with Babanki (Togaviridae)
and Kedougou (Flaviviridae) viruses. J Med Virol. 2003 Apr;69(4):503-9.
7860.
Koraka P, Murgue B, Deparis X, Setiati TE, Suharti C, van Gorp EC, Hack
CE, Osterhaus AD, Groen J. Elevated levels of total and dengue virus-specific
immunoglobulin E in patients with varying disease severity. J Med Virol. 2003
May;70(1):91-8.
7861.
Shu PY, Chang SF, Kuo YC, Yueh YY, Chien LJ, Sue CL, Lin TH, Huang JH.
Development of group- and serotype-specific one-step SYBR green I-based
real-time reverse transcription-PCR assay for dengue virus. J Clin Microbiol.
2003 Jun;41(6):2408-16.
7862.
Vazquez S, Valdes O, Pupo M, Delgado I, Alvarez M, Pelegrino JL, Guzman
MG. MAC-ELISA and ELISA inhibition methods for detection of antibodies after
yellow fever vaccination. J Virol Methods. 2003 Jun 30;110(2):179-84.
Pathogenesis
7863.
Blaney JE Jr, Manipon GG, Murphy BR, Whitehead SS.
Temperature sensitive mutations in the genes encoding the NS1, NS2A, NS3,
and NS5 nonstructural proteins of dengue virus type 4 restrict replication in
the brains of mice. Arch Virol. 2003 May;148(5):999-1006.
7864.
Cologna R, Rico-Hesse R.
American genotype structures decrease dengue virus output from human
monocytes and dendritic cells. J Virol. 2003 Apr;77(7):3929-38.
7865.
Jones CT, Ma L, Burgner JW, Groesch TD, Post CB, Kuhn RJ.
Flavivirus capsid is a dimeric alpha-helical protein. J Virol. 2003
Jun;77(12):7143-9.
7866.
Koraka P, Murgue B, Deparis X, Setiati TE, Suharti C, van Gorp EC, Hack
CE, Osterhaus AD, Groen J.
Elevated levels of total and dengue virus-specific immunoglobulin E in
patients with varying disease severity. J Med Virol. 2003 May;70(1):91-8.
7867.
Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke
J, Sun W, Eller MA, Pattanapanyasat K, Sarasombath S, Birx DL, Steinman RM,
Schlesinger S, Marovich MA.
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells.
J Exp Med. 2003 Apr 7;197(7):823-9.
7868.
Wei HY, Jiang LF, Xue YH, Fang DY, Guo HY.
Secreted expression of dengue virus type 2 full-length envelope
glycoprotein in Pichia pastoris. J Virol Methods. 2003 Apr;109(1):17-23.
Vaccines:
7869.
Konishi E, Terazawa A, Imoto J. Simultaneous immunization with DNA and
protein vaccines against Japanese encephalitis or dengue synergistically
increases their own abilities to induce neutralizing antibody in mice. Vaccine.
2003 May 16;21(17-18):1826-32.
7870.
Puttikhunt C, Kasinrerk W, Srisa-ad S, Duangchinda T, Silakate W, Moonsom
S, Sittisombut N, Malasit P. Production of anti-dengue NS1 monoclonal antibodies
by DNA immunization. J Virol Methods. 2003 Apr;109(1):55-61.
Therapy:
7871. Ostronoff M, Ostronoff F, Florencio R, Florencio M, Domingues MC, Calixto R, Sucupira A, Souto Maior AP, Matias C, Matias K, Tagliari C, Soussain C. Serious thrombocytopenia due to dengue hemorrhagic fever treated with high dosages of immunoglobulin. Clin Infect Dis. 2003 Jun 15;36(12):1623-4.
7872.
Puttikhunt
C, Kasinrerk W, Srisa-ad S, Duangchinda T, Silakate W, Moonsom S, Sittisombut N,
Malasit P. Production of anti-dengue NS1 monoclonal antibodies by DNA
immunization. J Virol Methods. 2003 Apr;109(1):55-61.